Most new, high-priced cancer drugs don’t even extend life for 10 weeks
Patient advocates are urging FDA and drug companies to set the bar higher.
Continue Reading https://arstechnica.comPatient advocates are urging FDA and drug companies to set the bar higher.
Continue Reading https://arstechnica.com
Join the Discussion